SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-007534
Filing Date
2024-03-11
Accepted
2024-03-11 18:00:20
Documents
1
Period of Report
2024-03-07

Document Format Files

Seq Description Document Type Size
1 form4-03112024_060307.html 4  
1 form4-03112024_060307.xml 4 22338
  Complete submission text file 0001415889-24-007534.txt   23816
Mailing Address C/O TARGANTA THERAPEUTICS CORPORATION 222 THIRD STREET SUITE 2300 CAMBRIDGE MA 02142
Business Address
Eldridge George A (Reporting) CIK: 0001413006 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40544 | Film No.: 24739466

Mailing Address 930 WINTER STREET SUITE M-500 WALTHAM MA 02451
Business Address 930 WINTER STREET SUITE M-500 WALTHAM MA 02451 617-443-2400
Aerovate Therapeutics, Inc. (Issuer) CIK: 0001798749 (see all company filings)

IRS No.: 831377888 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)